| Product Code: ETC5300844 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
The Angola Pharmaceuticals Market is poised for steady growth rate improvements from 2025 to 2029. The growth rate starts at 0.02% in 2025 and reaches 0.03% by 2029.

The Pharmaceuticals market in Angola is projected to grow at a stable growth rate of 0.03% by 2027, within the Africa region led by Egypt, along with other countries like South Africa, Ethiopia, Algeria and Nigeria, collectively shaping a dynamic and evolving market environment driven by innovation and increasing adoption of emerging technologies.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Angola Pharmaceuticals Market Overview |
3.1 Angola Country Macro Economic Indicators |
3.2 Angola Pharmaceuticals Market Revenues & Volume, 2021 & 2031F |
3.3 Angola Pharmaceuticals Market - Industry Life Cycle |
3.4 Angola Pharmaceuticals Market - Porter's Five Forces |
3.5 Angola Pharmaceuticals Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Angola Pharmaceuticals Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.7 Angola Pharmaceuticals Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Angola Pharmaceuticals Market Revenues & Volume Share, By Drug Classification, 2021 & 2031F |
3.9 Angola Pharmaceuticals Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
4 Angola Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing healthcare expenditure in Angola |
4.2.2 Rising prevalence of chronic diseases in the country |
4.2.3 Government initiatives to improve healthcare infrastructure and services |
4.3 Market Restraints |
4.3.1 Limited access to quality healthcare services in remote areas |
4.3.2 High import dependency for pharmaceutical products |
4.3.3 Regulatory challenges and complexities in the pharmaceutical sector |
5 Angola Pharmaceuticals Market Trends |
6 Angola Pharmaceuticals Market Segmentations |
6.1 Angola Pharmaceuticals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Angola Pharmaceuticals Market Revenues & Volume, By Pharmaceutical Drugs, 2021-2031F |
6.1.3 Angola Pharmaceuticals Market Revenues & Volume, By Biologics, 2021-2031F |
6.2 Angola Pharmaceuticals Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Angola Pharmaceuticals Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.2.3 Angola Pharmaceuticals Market Revenues & Volume, By Retail Pharmacies/ Drug Stores, 2021-2031F |
6.2.4 Angola Pharmaceuticals Market Revenues & Volume, By Others, 2021-2031F |
6.3 Angola Pharmaceuticals Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Angola Pharmaceuticals Market Revenues & Volume, By Oral, 2021-2031F |
6.3.3 Angola Pharmaceuticals Market Revenues & Volume, By Parenteral, 2021-2031F |
6.3.4 Angola Pharmaceuticals Market Revenues & Volume, By Others, 2021-2031F |
6.4 Angola Pharmaceuticals Market, By Drug Classification |
6.4.1 Overview and Analysis |
6.4.2 Angola Pharmaceuticals Market Revenues & Volume, By Branded Drugs, 2021-2031F |
6.4.3 Angola Pharmaceuticals Market Revenues & Volume, By Generic Drugs, 2021-2031F |
6.5 Angola Pharmaceuticals Market, By Mode of Purchase |
6.5.1 Overview and Analysis |
6.5.2 Angola Pharmaceuticals Market Revenues & Volume, By Prescription-Based Drugs, 2021-2031F |
6.5.3 Angola Pharmaceuticals Market Revenues & Volume, By Over-The-Counter Drugs, 2021-2031F |
7 Angola Pharmaceuticals Market Import-Export Trade Statistics |
7.1 Angola Pharmaceuticals Market Export to Major Countries |
7.2 Angola Pharmaceuticals Market Imports from Major Countries |
8 Angola Pharmaceuticals Market Key Performance Indicators |
8.1 Percentage of population covered by healthcare insurance |
8.2 Number of healthcare facilities per capita |
8.3 Investment in pharmaceutical research and development |
8.4 Percentage of essential medicines available in public health facilities |
8.5 Healthcare expenditure as a percentage of GDP |
9 Angola Pharmaceuticals Market - Opportunity Assessment |
9.1 Angola Pharmaceuticals Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Angola Pharmaceuticals Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.3 Angola Pharmaceuticals Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Angola Pharmaceuticals Market Opportunity Assessment, By Drug Classification, 2021 & 2031F |
9.5 Angola Pharmaceuticals Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
10 Angola Pharmaceuticals Market - Competitive Landscape |
10.1 Angola Pharmaceuticals Market Revenue Share, By Companies, 2024 |
10.2 Angola Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |